Virtual Screening of Novel 24-Dehydroxysterol Reductase (DHCR24) Inhibitors and the Biological Evaluation of Irbesartan in Cholesterol-Lowering Effect

Hyperlipidemia is a risk factor for the development of fatty liver and cardiovascular diseases such as atherosclerosis and coronary heart disease, and hence, cholesterol-lowering drugs are considered important and effective in preventing cardiovascular diseases. Thus, researchers in the field of new...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Haozhen, Lu, Ziyin, Li, Yang, Liu, Ting, Zhao, Linlin, Gao, Tianqi, Lu, Xiuli, Gao, Bing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10053925/
https://www.ncbi.nlm.nih.gov/pubmed/36985615
http://dx.doi.org/10.3390/molecules28062643

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10053925/
https://www.ncbi.nlm.nih.gov/pubmed/36985615
http://dx.doi.org/10.3390/molecules28062643

Ejemplares similares